Skip to main content
. 2015 Dec 14;26(4):473–480. doi: 10.3109/14397595.2015.1109182

Table 3. Number of CZP-ADAb positive patients at any time during 24 weeks treatment.

  J-RAPID
HIKARI
  Total patients
CZP-ADAb positive patients
Total patients
CZP-ADAb positive patients
Groups N n % N n %
LD 82 1 1.2 116 20 17.2
No-LD 61 3 4.9 99 27 27.3

CZP-ADAb, antibodies to CZP; LD, loading dose.